UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,245 | +35.4% | 24,500 | 0.0% | 0.03% | +60.0% |
| Q2 2023 | $253,575 | +12.0% | 24,500 | 0.0% | 0.02% | +5.3% |
| Q1 2023 | $226,380 | +4.2% | 24,500 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $217,315 | +6.5% | 24,500 | 0.0% | 0.02% | +18.8% |
| Q3 2022 | $204,000 | +1.5% | 24,500 | 0.0% | 0.02% | -11.1% |
| Q2 2022 | $201,000 | -5.6% | 24,500 | 0.0% | 0.02% | +12.5% |
| Q1 2022 | $213,000 | -8.6% | 24,500 | 0.0% | 0.02% | +6.7% |
| Q4 2021 | $233,000 | -43.4% | 24,500 | 0.0% | 0.02% | -40.0% |
| Q3 2021 | $412,000 | +10.2% | 24,500 | 0.0% | 0.02% | +19.0% |
| Q2 2021 | $374,000 | -21.6% | 24,500 | 0.0% | 0.02% | -22.2% |
| Q1 2021 | $477,000 | +8.2% | 24,500 | 0.0% | 0.03% | +17.4% |
| Q4 2020 | $441,000 | -6.8% | 24,500 | 0.0% | 0.02% | -11.5% |
| Q3 2020 | $473,000 | -26.1% | 24,500 | 0.0% | 0.03% | -31.6% |
| Q2 2020 | $640,000 | +46.5% | 24,500 | 0.0% | 0.04% | +2.7% |
| Q1 2020 | $437,000 | – | 24,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |